985
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Physical fitness and physical activity in fatigued and non-fatigued inflammatory bowel disease patients

, , , , &
Pages 1357-1367 | Received 14 Mar 2015, Accepted 26 Apr 2015, Published online: 20 May 2015

References

  • Jelsness-Jorgensen LP, Bernklev T, Henriksen M, Torp R, Moum BA. Chronic fatigue is associated with impaired health-related quality of life in inflammatory bowel disease. Aliment Pharmacol Ther 2011;33:106–14.
  • Minderhoud IM, Oldenburg B, van Dam PS, van Berge Henegouwen GP. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol 2003;98:1088–93.
  • Romberg-Camps MJ, Bol Y, Dagnelie PC, Hesselink-van de Kruijs MA, Kester AD, Engels LG, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg cohort. Inflamm Bowel Dis 2010;16:2137–47.
  • Castillo-Cejas MD, Robles V, Borruel N, Torrejon A, Navarro E, Pelaez A, et al. Questionnaries for measuring fatigue and its impact on health perception in inflammatory bowel disease. Rev Esp Enferm Dig 2013;105:144–53.
  • Vogelaar L, Van’t Spijker A, van Tilburg AJ, Kuipers EJ, Timman R, van der Woude CJ. Determinants of fatigue in Crohn’s disease patients. Eur J Gastroenterol Hepatol 2013;25:246–51.
  • de Rooy EC, Toner BB, Maunder RG, Greenberg GR, Baron D, Steinhart AH, et al. Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol 2001;96:1816–21.
  • Graff LA, Vincent N, Walker JR, Clara I, Carr R, Ediger J, et al. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm Bowel Dis 2011;17:1882–9.
  • Lix LM, Graff LA, Walker JR, Clara I, Rawsthorne P, Rogala L, et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis 2008;14:1575–84.
  • Janke KH, Klump B, Gregor M, Meisner C, Haeuser W. Determinants of life satisfaction in inflammatory bowel disease. Inflamm Bowel Dis 2005;11:272–86.
  • Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004;39:365–73.
  • Mussell M, Bocker U, Nagel N, Singer MV. Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004;16:1273–80.
  • Casellas F, Lopez-Vivancos J, Badia X, Vilaseca J, Malagelada JR. Influence of inflammatory bowel disease on different dimensions of quality of life. Eur J Gastroenterol Hepatol 2001;13:567–72.
  • Vogelaar L, Van’t Spijker A, Timman R, van Tilburg AJ, Bac D, Vogelaar T, et al. Fatigue management in patients with IBD: a randomised controlled trial. Gut 2014;63:911–8.
  • Aadahl M, Hansen BA, Kirkegaard P, Groenvold M. Fatigue and physical function after orthotopic liver transplantation. Liver Transpl 2002;8:251–9.
  • Brown DJ, McMillan DC, Milroy R. The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 2005;103:377–82.
  • Kummer F, Catuogno S, Perseus JM, Bloch W, Baumann FT. Relationship between cancer-related fatigue and physical activity in inpatient cancer rehabilitation. Anticancer Res 2013;33:3415–22.
  • van Ginneken BT, van den Berg-Emons RJ, Kazemier G, Metselaar HJ, Tilanus HW, Stam HJ. Physical fitness, fatigue, and quality of life after liver transplantation. Eur J Appl Physiol 2007;100:345–53.
  • van den Berg-Emons R, Kazemier G, van Ginneken B, Nieuwenhuijsen C, Tilanus H, Stam H. Fatigue, level of everyday physical activity and quality of life after liver transplantation. J Rehabil Med 2006;38:124–9.
  • Kummer F, Catuogno S, Perseus JM, Bloch W, Baumann FT. Relationship between cancer-related fatigue and physical activity in inpatient cancer rehabilitation. Anticancer Res 2013;33:3415–22.
  • van den Berg-Emons RJ, van Ginneken BT, Nooijen CF, Metselaar HJ, Tilanus HW, Kazemier G, et al. Fatigue after liver transplantation: effects of a rehabilitation program including exercise training and physical activity counseling. Phys Ther 2014;94:857–65.
  • Ergun M, Eyigor S, Karaca B, Kisim A, Uslu R. Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients. Eur J Cancer Care (Engl) 2013;22:626–37.
  • Banzer W, Bernhorster M, Schmidt K, Niederer D, Lungwitz A, Thiel C, et al. Changes in exercise capacity, quality of life and fatigue in cancer patients during an intervention. Eur J Cancer Care (Engl) 2014;23:624–9.
  • McMillan EM, Newhouse IJ. Exercise is an effective treatment modality for reducing cancer-related fatigue and improving physical capacity in cancer patients and survivors: a meta-analysis. Appl Physiol Nutr Metab 2011;36:892–903.
  • Battaglini CL. Physical activity and hematological cancer survivorship. Recent Results Cancer Res 186:275–304.
  • Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O. Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 2012;8:CD008465.
  • Vercoulen JH, Alberts M, Bleijenberg G. De checklist individual strength (CIS). Gedragtherapie 1999;32:131–6.
  • Cardinal BJ, Esters J, Cardinal MK. Evaluation of the revised physical activity readiness questionnaire in older adults. Med Sci Sports Exerc 1996;28:468–72.
  • Thompson PD, Arena R, Riebe D, Pescatello LS. ACSM’s new preparticipation health screening recommendations from ACSM’s guidelines for exercise testing and prescription, ninth edition. Curr Sports Med Rep 2013;12:215–17.
  • Nakanishi M, Takaki H, Kumasaka R, Arakawa T, Noguchi T, Sugimachi M, et al. Targeting of high peak respiratory exchange ratio is safe and enhances the prognostic power of peak oxygen uptake for heart failure patients. Circ J 2014;78:2268–75.
  • Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, et al. Clinician’s Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010;122:191–225.
  • Chase PJ, Kenjale A, Cahalin LP, Arena R, Davis PG, Myers J, et al. Effects of respiratory exchange ratio on the prognostic value of peak oxygen consumption and ventilatory efficiency in patients with systolic heart failure. JACC Heart Fail 2013;1:427–32.
  • Tanaka H, Monahan KD, Seals DR. Age-predicted maximal heart rate revisited. J Am Coll Cardiol 2001;37:153–6.
  • Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14:377–81.
  • Noble BJ, Borg GA, Jacobs I, Ceci R, Kaiser P. A category-ratio perceived exertion scale: relationship to blood and muscle lactates and heart rate. Med Sci Sports Exerc 1983;15:523–8.
  • Caiozzo VJ, Davis JA, Ellis JF, Azus JL, Vandagriff R, Prietto CA, et al. A comparison of gas exchange indices used to detect the anaerobic threshold. J Appl Physiol Respir Environ Exerc Physiol 1982;53:1184–9.
  • Reinhard U, Muller PH, Schmulling RM. Determination of anaerobic threshold by the ventilation equivalent in normal individuals. Respiration 1979;38:36–42.
  • Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985;132:919–23.
  • Bussmann JB, Martens WL, Tulen JH, Schasfoort FC, van den Berg-Emons HJ, Stam HJ. Measuring daily behavior using ambulatory accelerometry: the Activity Monitor. Behav Res Methods Instrum Comput 2001;33:349–56.
  • Jain A, Martens WLJ, Mutz G. Towards a comprehensive technology for recording and analysis of multiple physiological parameters within their behavioral and environmental context. In Fahrenberg J, Myrtek M, editors. Ambulatory assessment; computerassisted psychological and psychophysiological methods in monitoring and field studies. Seattle: Hogrefe & Huber Publishers; 1996. pp 215–36.
  • van den Berg-Emons H, Bussmann J, Balk A, Keijzer-Oster D, Stam H. Level of activities associated with mobility during everyday life in patients with chronic congestive heart failure as measured with an "activity monitor". Phys Ther 2001;81:1502–11.
  • Bouten CV, Westerterp KR, Verduin M, Janssen JD. Assessment of energy expenditure for physical activity using a triaxial accelerometer. Med Sci Sports Exerc 1994;26:1516–23.
  • Bussmann JB, Hartgerink I, van der Woude LH, Stam HJ. Measuring physical strain during ambulation with accelerometry. Med Sci Sports Exerc 2000;32:1462–71.
  • Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr 1974;32:77–97.
  • Durnin JV, Rahaman MM. The assessment of the amount of fat in the human body from measurements of skinfold thickness. Br J Nutr 1967;21:681–9.
  • Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet 1980;1:514.
  • Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841–5.
  • Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749–53.
  • Cohen J. A power primer. Psychol Bull 1992;112:155–9.
  • Fairbarn MS, Blackie SP, McElvaney NG, Wiggs BR, Pare PD, Pardy RL. Prediction of heart rate and oxygen uptake during incremental and maximal exercise in healthy adults. Chest 1994;105:1365–9.
  • Gibbons WJ, Fruchter N, Sloan S, Levy RD. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 2001;21:87–93.
  • Akima H, Kano Y, Enomoto Y, Ishizu M, Okada M, Oishi Y, et al. Muscle function in 164 men and women aged 20–84 yr. Med Sci Sports Exerc 2001;33:220–6.
  • van den Berg-Emons RJ, Bussmann JB, Stam HJ. Accelerometry-based activity spectrum in persons with chronic physical conditions. Arch Phys Med Rehabil 2010;91:1856–61.
  • Rawsthorne P, Shanahan F, Cronin NC, Anton PA, Lofberg R, Bohman L, et al. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 1999;94:1298–303.
  • Laukkanen JA, Laaksonen D, Lakka TA, Savonen K, Rauramaa R, Makikallio T, et al. Determinants of cardiorespiratory fitness in men aged 42 to 60 years with and without cardiovascular disease. Am J Cardiol 2009;103:1598–604.
  • Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46–56.
  • Granger JI, Ratti PL, Datta SC, Raymond RM, Opp MR. Sepsis-induced morbidity in mice: effects on body temperature, body weight, cage activity, social behavior and cytokines in brain. Psychoneuroendocrinology 2013;38:1047–57.
  • Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am 2009;29:247–64.
  • Fakhoury M, Negrulj R, Mooranian A, Al-Salami H. Inflammatory bowel disease: clinical aspects and treatments. J Inflamm Res 2014;7:113–20.
  • Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology 2013;144:36–49.
  • Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol 2014;14:329–42.
  • van Langenberg DR, Della Gatta P, Warmington SA, Kidgell DJ, Gibson PR, Russell AP. Objectively measured muscle fatigue in Crohn’s disease: Correlation with self-reported fatigue and associated factors for clinical application. J Crohns Colitis 2014;8:137–46.
  • Roubenoff R. Exercise and inflammatory disease. Arthritis Rheum 2003;49:263–6.
  • Zoico E, Roubenoff R. The role of cytokines in regulating protein metabolism and muscle function. Nutr Rev 2002;60:39–51.
  • Glass D, Roubenoff R. Recent advances in the biology and therapy of muscle wasting. Ann N Y Acad Sci 2010;1211:25–36.
  • Al-Majid S, Waters H. The biological mechanisms of cancer-related skeletal muscle wasting: the role of progressive resistance exercise. Biol Res Nurs 2008;10:7–20.
  • Drey M. Sarcopenia - pathophysiology and clinical relevance. Wien Med Wochenschr 2011;161:402–8.
  • Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 2002;57:M326–32.
  • Patel HP, Al-Shanti N, Davies LC, Barton SJ, Grounds MD, Tellam RL, et al. Lean mass, muscle strength and gene expression in community dwelling older men: findings from the Hertfordshire Sarcopenia Study (HSS). Calcif Tissue Int 2014;95:308–16.
  • Nader GA, Lundberg IE. Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle. Curr Opin Rheumatol 2009;21:599–603.
  • Nakamura Y, Tanaka K, Shigematsu R, Homma T, Sekizawa K. Determinants of cardiorespiratory fitness in patients with chronic obstructive pulmonary disease, focusing on activities parallel to daily living. Respirology 2004;9:326–30.
  • Baert I, Vanlandewijck Y, Feys H, Vanhees L, Beyens H, Daly D. Determinants of cardiorespiratory fitness at 3, 6 and 12 months poststroke. Disabil Rehabil 2012;34:1835–42.
  • Geerling BJ, Badart-Smook A, Stockbrugger RW, Brummer RJ. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 1998;67:919–26.
  • Valentini L, Schaper L, Buning C, Hengstermann S, Koernicke T, Tillinger W, et al. Malnutrition and impaired muscle strength in patients with Crohn’s disease and ulcerative colitis in remission. Nutrition 2008;24:694–702.
  • Wiroth JB, Filippi J, Schneider SM, Al-Jaouni R, Horvais N, Gavarry O, et al. Muscle performance in patients with Crohn’s disease in clinical remission. Inflamm Bowel Dis 2005;11:296–303.
  • Topp KS, Painter PL, Walcott S, Krasnoff JB, Adey D, Sakkas GK, et al. Alterations in skeletal muscle structure are minimized with steroid withdrawal after renal transplantation. Transplantation 2003;76:667–73.
  • Gupta A, Gupta Y. Glucocorticoid-induced myopathy: Pathophysiology, diagnosis, and treatment. Indian J Endocrinol Metab 2013;17:913–16.
  • Pereira RM, Freire de Carvalho J. Glucocorticoid-induced myopathy. Joint Bone Spine 2011;78:41–4.
  • Zaltman C, Braulio VB, Outeiral R, Nunes T, de Castro CL. Lower extremity mobility limitation and impaired muscle function in women with ulcerative colitis. J Crohns Colitis 2014;8:529–35.
  • Mulder ER, Stegeman DF, Gerrits KH, Paalman MI, Rittweger J, Felsenberg D, et al. Strength, size and activation of knee extensors followed during 8 weeks of horizontal bed rest and the influence of a countermeasure. Eur J Appl Physiol 2006;97:706–15.
  • van den Berg-Emons RJ, Bussmann JB, Balk AH, Stam HJ. Factors associated with the level of movement-related everyday activity and quality of life in people with chronic heart failure. Phys Ther 2005;85:1340–8.
  • Garcia-Vega E, Fernandez-Rodriguez C. A stress management programme for Crohn’s disease. Behav Res Ther 2004;42:367–83.
  • Mussell M, Bocker U, Nagel N, Olbrich R, Singer MV. Reducing psychological distress in patients with inflammatory bowel disease by cognitive-behavioural treatment: exploratory study of effectiveness. Scand J Gastroenterol 2003;38:755–62.
  • Milne B, Joachim G, Niedhardt J. A stress management programme for inflammatory bowel disease patients. J Adv Nurs 1986;11:561–7.
  • Vogelaar L, Spijker AV, van der Woude CJ. The impact of biologics on health-related quality of life in patients with inflammatory bowel disease. Clin Exp Gastroenterol 2009;2:101–9.
  • Packer N, Hoffman-Goetz L, Ward G. Does physical activity affect quality of life, disease symptoms and immune measures in patients with inflammatory bowel disease? A systematic review. J Sports Med Phys Fitness 2010;50:1–18.
  • Loudon CP, Corroll V, Butcher J, Rawsthorne P, Bernstein CN. The effects of physical exercise on patients with Crohn’s disease. Am J Gastroenterol 1999;94:697–703.
  • Perez CA. Prescription of physical exercise in Crohn’s disease. J Crohns Colitis 2009;3:225–31.
  • Ng V, Millard W, Lebrun C, Howard J. Exercise and Crohn’s disease: speculations on potential benefits. Can J Gastroenterol 2006;20:657–60.
  • Ng V, Millard W, Lebrun C, Howard J. Low-intensity exercise improves quality of life in patients with Crohn’s disease. Clin J Sport Med 2007;17:384–8.
  • van Ginneken BT, van den Berg-Emons HJ, Metselaar HJ, Tilanus HW, Kazemier G, Stam HJ. Effects of a rehabilitation programme on daily functioning, participation, health-related quality of life, anxiety and depression in liver transplant recipients. Disabil Rehabil 2010;32:2107–12.
  • Mehnert A, Veers S, Howaldt D, Braumann KM, Koch U, Schulz KH. Effects of a physical exercise rehabilitation group program on anxiety, depression, body image, and health-related quality of life among breast cancer patients. Onkologie 2011;34:248–53.
  • Goksel Karatepe A, Gunaydin R, Turkmen G, Kaya T. Effects of home-based exercise program on the functional status and the quality of life in patients with rheumatoid arthritis: 1-year follow-up study. Rheumatol Int 2011;31:171–6.
  • Garrett M, Hogan N, Larkin A, Saunders J, Jakeman P, Coote S. Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial. Mult Scler 2013;19:782–9.
  • Pilutti L, Dlugonski D, Sandroff B, Klaren R, Motl R. Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis. Mult Scler 2014;20(5):594–601.
  • Stenstrom CH. Home exercise in rheumatoid arthritis functional class II: goal setting versus pain attention. J Rheumatol 1994;21:627–34.
  • D’Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis 2012;18:2218–24.
  • Anforth HR, Bluthe RM, Bristow A, Hopkins S, Lenczowski MJ, Luheshi G, et al. Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur Cytokine Netw 1998;9:279–88.
  • Morris G, Anderson G, Galecki P, Berk M, Maes M. A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior. BMC Med 2013;11:64.
  • Maes M, Berk M, Goehler L, Song C, Anderson G, Galecki P, et al. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways. BMC Med 2012;10:66.
  • Bower JE, Ganz PA, Aziz N, Fahey JL. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med 2002;64:604–11.
  • Charters Y, Grimble RF. Effect of recombinant human tumour necrosis factor alpha on protein synthesis in liver, skeletal muscle and skin of rats. Biochem J 1989;258:493–7.
  • Goodman MN. Tumor necrosis factor induces skeletal muscle protein breakdown in rats. Am J Physiol 1991;260:E727–30.
  • Garcia-Martinez C, Lopez-Soriano FJ, Argiles JM. Acute treatment with tumour necrosis factor-alpha induces changes in protein metabolism in rat skeletal muscle. Mol Cell Biochem 1993;125:11–18.
  • Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin ASJr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 2000;289:2363–6.
  • Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994;93:2379–86.
  • Anker SD, Ponikowski PP, Clark AL, Leyva F, Rauchhaus M, Kemp M, et al. Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure. Eur Heart J 1999;20:683–93.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.